IL6 and congenital rubella syndrome: CAR T-cells elicit a robust immune response characterized by a substantial systemic release of pro-inflammatory cytokines, including TNF-α, IFN-γ, and IL-6, which in turn activate prostaglandin pathways and precipitate CRS [83].